EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Open Access

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis

Mathew S Maurer iD, Parag Kale, Marianna Fontana, John L Berk, Martha Grogan, Finn Gustafsson, Rebecca R Hung, Robert L Gottlieb iD, Thibaud Damy, Alejandra González-Duarte, Nitasha Sarswat, Yoshiki Sekijima und 26 weitere

New England Journal of Medicine · 26.10.2023 · 389 (17) · 1553-1565

DOI: 10.1056/nejmoa2300757 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 26.10.2023. Verfasst von Mathew S Maurer und 37 weiteren Autor:innen. Beteiligte Einrichtung: From Columbia University Irving Medical Center (M.S.M.) and Grossman School of Medicine, NYU Langone (A.G.-D.) - both in New York; the Center for Adv…. Hauptthemen laut MEDLINE: Cardiomyopathies, Prealbumin, RNA, Small Interfering, Amyloidosis. Die Arbeit wurde bisher 352-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NCATS NIH HHS, Alnylam Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesPrealbuminRNA, Small InterferingAmyloidosisHumansAmyloidosis, FamilialLiverDouble-Blind Method

Substanzen

patisiranPrealbuminRNA, Small Interfering

Autor:innen und Institutionen

  • From Columbia University Irving Medical Center (M.S.M.) and Grossman School of Medicine, NYU Langone (A.G.-D.) - both in New York; the Center for Advanced Heart and Lung Disease, Baylor University Medical Center (P.K.,…

ORCID-Profile: Mathew S Maurer, Robert L Gottlieb, Nobuhiro Tahara

Förderung

  • NIA NIH HHS
  • NCATS NIH HHS
  • Alnylam Pharmaceuticals

Zitieren

APA

Maurer, M. S., Kale, P., Fontana, M., Berk, J. L., Grogan, M., Gustafsson, F., Hung, R. R., Gottlieb, R. L., Damy, T., González-Duarte, A., Sarswat, N., Sekijima, Y., Tahara, N., Taylor, M. S., Kubanek, M., Donal, E., Palecek, T., Tsujita, K., Tang, W. H. W., …, & APOLLO-B Trial Investigators (2023). Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis. New England Journal of Medicine, 389(17), 1553-1565. https://doi.org/10.1056/nejmoa2300757

Vancouver

Maurer MS, Kale P, Fontana M, Berk JL, Grogan M, Gustafsson F, et al. Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis. New England Journal of Medicine. 2023;389(17):1553-1565. doi:10.1056/nejmoa2300757

BibTeX
@article{Maurer2023,
  author = {Maurer, Mathew S and Kale, Parag and Fontana, Marianna and Berk, John L and Grogan, Martha and Gustafsson, Finn and Hung, Rebecca R and Gottlieb, Robert L and Damy, Thibaud and González-Duarte, Alejandra and Sarswat, Nitasha and Sekijima, Yoshiki and Tahara, Nobuhiro and Taylor, Mark S and Kubanek, Milos and Donal, Erwan and Palecek, Tomas and Tsujita, Kenichi and Tang, W H Wilson and Yu, Wen-Chung and Obici, Laura and Simões, Marcus and Fernandes, Fábio and Poulsen, Steen Hvitfeldt and Diemberger, Igor and Perfetto, Federico and Solomon, Scott D and Di Carli, Marcelo and Badri, Prajakta and White, Matthew T and Chen, Jihong and Yureneva, Elena and Sweetser, Marianne T and Jay, Patrick Y and Garg, Pushkal P and Vest, John and Gillmore, Julian D and APOLLO-B Trial Investigators, APOLLO-B Trial Investigators},
  title = {Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {389},
  number = {17},
  pages = {1553--1565},
  doi = {10.1056/nejmoa2300757}
}
Kostenlos starten →